In this work, they evaluated cell proliferation, apoptosis, the distribution of cell cycle phases, the IC50 values of cisplatin, gefitinib, and paclitaxel, the volume of the implanted tumor, and the expression of survivin in mice treated with RSV compared to the control. Here, BIRC5 is linked to neoplasm.